P1.18 Evaluation of the cobas® hsv 1 and 2 test in a japanese population. (8th July 2017)

• Record Type: Journal Article
• Authors: Marlowe, Elizabeth; Kawana, Takashi; Onoe, Tomohiko; Onoe, Yasuhiko; Sawamura, Masayuki; Hayakawa, Kenichi; Lewinski, Michael; Ohse, Rui; Takiyama, Ai
• Is Part Of: Sexually transmitted infections. Volume 93(2017)Supplement 2
• Page Start: A50
• Page End: A51
• Publication Date: 2017-07-08
• Subjects: Sexually transmitted diseases -- Periodicals; HIV infections -- Periodicals; 616.951005
• DOI: 10.1136/sextrans-2017-053264.126
• Languages: English
• ISSNs: 1368-4973

Abstract

Abstract : Introduction: Herpes is a common cause of sexually transmitted disease, which is often asymptomatic. Identification of genital herpes can impact the clinical management of patients who are HIV positive, immunosuppressed, pregnant, and individuals with HSV seronegative partners. The objective of this study was to evaluate the performance of the cobas ® HSV 1 and 2 test in a Japanese population. Methods: A total of 165 specimens of anogential lesions and endocervcal swabs from 122 patients were tested from clinical sites in Tokyo, Kanagawa and Osaka (36% Female, 64% Male). Specimens were tested by cobas ® HSV 1 and 2 test (cHSV) and compared to shell vial culture (SV) as well as Prime Check HSV Antigen Detection Kit (PCA) and direct immunofluorescence (DFA). Diagnostic agreement was evaluated and discrepant analysis was performed by Sanger sequencing. Results: The overall percent agreement (OPA), sensitivity and specificity of cHSV compared to SV for HSV-1 was 98.8% (95% CI 95.7–99.9), 100% (95% CI 97.8%–100%), and 98.5% (95% CI 95.3–99.8), and for HSV-2 was 87.9% (95% CI 81.9–92.5), 98.6% (95% CI 95.4%–99.8%), and 79.6% (95% CI 72.6%–85.4%), respectively. For HSV-1 there were 2 cHSV+/SV-. For HSV-2 there were 20 discordant results, 19 cHSV+/SV- and 1 cHSV-/SV+. Sanger Sequencing for HSV-1 confirmed 1 of 2 positive for HSV-1 and for HSV-2 confirmed 20/20 as HSV-2 positive. Both PCA and DFA missed more than twice as many confirmed positive HSV specimens as SV. The OPA, sensitivity and specificity of cHSV compared to DFA for HSV-1 was 84.8% (95% CI 78.4–89.9), 85.7% (95% CI 79.4%–90.7%), and 84.7% (95% CI 78.3%–89.8%), and for HSV-2 was 59.8% (95% CI 51.9%–67.4%), 100% (95% CI 97.8%–100%), and 53.2% (95% CI 45.3%–61.0%), respectively. PCA does not type positive HSV. The OPA, sensitivity and specificity of cHSV compared to PCA was 74.5% (95% CI 67.1%–81.0%), 98.8% (95% CI 95.6%–99.8%), and 51.8% (95% CI 43.9%–59.6%). Conclusion: This study demonstrated improved diagnostic performance of the cobas HSV 1 and 2 test compared to routine methods in a Japanese population.